İrFan Sahin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
İrFan Sahin has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Ertuğrul Okuyan
Istanbul Medipol Üniversitesi
9 shared publications - Sevgi Özcan
Department of Cardiology, Bagcılar Training and Research Hospital, İstanbul, Türkiye
7 shared publications - Esra Dönmez
Department of Cardiology, Bagcilar Training and Research Hospital, Istanbul, Turkey
6 shared publications - Emirhan Hancıoğlu
Department of Cardiology, Medipol University School of Medicine, İstanbul 34083, Turkey
3 shared publications - Emre Melik Faideci
Department of Cardiology Bilecik Training and Research Hospital Bilecik Turkey
2 shared publications - Orhan İnCe
Department of Cardiology, Bagcilar Training and Research Hospital, Istanbul 34200, Turkey
2 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 7943
Coffee Consumption, Serum Copeptin, and Selected Echocardiographic Parameters in Patients with ADPKD: A Cross-Sectional Study
Background/Objectives: Coffee consumption has been suggested to influence arginine vasopressin-related pathways and cardiovascular function. However, its relationships with serum copeptin and cardiac parameters in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear. This study aimed to investigate the association between habitual coffee consumption and serum copeptin concentrations and selected echocardiographic parameters in patients with ADPKD. Methods: In this cross-sectional study, 73 patients with ADPKD were classified as coffee consumers (n = 35) or non-consumers (n = 38). Serum copeptin measurements were available for 62 patients. Coffee consumption was assessed using a standardized questionnaire and expressed as grams of dry coffee per month. Multivariable models were used to assess associations with log-transformed copeptin, mitral annular e′ velocity, and E/e′ ratio. Results: Serum copeptin levels were lower among coffee consumers than non-consumers (median, 263.51 vs. 332.77 ng/L; p = 0.013). After adjustment, coffee consumption was associated with lower log-transformed copeptin levels (B = −0.263; p = 0.047), although this association was not statistically significant when using heteroskedasticity-consistent (HC3) robust standard errors (p = 0.074). Coffee consumers had higher mitral annular e′ velocity (8.61 vs. 5.86 cm/s; p < 0.001), which remained significant after adjustment (B = 2.531; p < 0.001), and a lower E/e′ ratio (B = −4.548; p = 0.007). Conclusions: In this ADPKD cohort, coffee consumption was associated with lower serum copeptin levels, higher mitral annular e′ velocity, and lower E/e′ ratio. These findings raise the hypothesis that habitual coffee consumption may be associated with vasopressin–copeptin system activity and diastolic myocardial relaxation in patients with ADPKD. However, the copeptin association was not robust to HC3 analysis, and the echocardiographic findings should be considered exploratory.
- 14 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 7943
Open AccessCoffee Consumption, Serum Copeptin, and Selected Echocardiographic Parameters in Patients with ADPKD: A Cross-Sectional Study
Background/Objectives: Coffee consumption has been suggested to influence arginine vasopressin-related pathways and cardiovascular function. However, its relationships with serum copeptin and cardiac parameters in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear. This study aimed to investigate the association between habitual coffee consumption and serum copeptin concentrations and selected echocardiographic parameters in patients with ADPKD. Methods: In this cross-sectional study, 73 patients with ADPKD were classified as coffee consumers (n = 35) or non-consumers (n = 38). Serum copeptin measurements were available for 62 patients. Coffee consumption was assessed using a standardized questionnaire and expressed as grams of dry coffee per month. Multivariable models were used to assess associations with log-transformed copeptin, mitral annular e′ velocity, and E/e′ ratio. Results: Serum copeptin levels were lower among coffee consumers than non-consumers (median, 263.51 vs. 332.77 ng/L; p = 0.013). After adjustment, coffee consumption was associated with lower log-transformed copeptin levels (B = −0.263; p = 0.047), although this association was not statistically significant when using heteroskedasticity-consistent (HC3) robust standard errors (p = 0.074). Coffee consumers had higher mitral annular e′ velocity (8.61 vs. 5.86 cm/s; p < 0.001), which remained significant after adjustment (B = 2.531; p < 0.001), and a lower E/e′ ratio (B = −4.548; p = 0.007). Conclusions: In this ADPKD cohort, coffee consumption was associated with lower serum copeptin levels, higher mitral annular e′ velocity, and lower E/e′ ratio. These findings raise the hypothesis that habitual coffee consumption may be associated with vasopressin–copeptin system activity and diastolic myocardial relaxation in patients with ADPKD. However, the copeptin association was not robust to HC3 analysis, and the echocardiographic findings should be considered exploratory.
- 26 May 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 108 (2) , 426-436
PCI for Ostial Stenosis of Left Circumflex or Left Anterior Descending Artery
Background: To date, the clinical outcome of ostial stent implantation (OSI) in patients with ostial left circumflex artery (LCX) or left anterior descending artery (LAD) lesions has not been well established. This study sought to assess the cardiovascular outcomes of the ostial stent implantation (OSI) for the ostial LAD or LCX lesions under long‐term follow‐up. Methods: This large‐scale, multicenter ( n = 13) observational, retrospective study included 839 patients (men: 619 [73.8%], mean age: 61.36 ± 11.93 years) who underwent PCI with OSI for ostial LAD or LCX lesions between 2014 and 2025. The primary outcome was major adverse cardiac events (MACE), including cardiac death, target lesion revascularisation, and target vessel myocardial infarction. Results: The study cohort was divided into two groups: ostial LAD ( n = 590) and ostial LCX ( n = 249) revascularized with OSI. SYNTAX scores and the utilization of intravascular imaging rates were similar in both groups. Total stent length (22.79 ± 7.37 vs. 24.60 ± 7.57 mm, p = 0.001) was notably lower in the LCX group; however, the rate of bailout 2‐stent technique (6.4 vs. 2.7%, p = 0.010) was significantly higher in the LCX group than in the LAD group. The risk‐adjusted long‐term MACE (HR: 1.591, p = 0.010) significantly differed in individuals with left‐sided ostial lesions to revascularize with OSI. Additionally, diabetes mellitus, chronic kidney disease, intravascular imaging, reduced left ventricle ejection fraction, high SYNTAX score, statin usage, and total stent length were found to be independent predictors of MACE. Conclusions: This multicenter study demonstrates that the location of ostial stenosis in LCX was associated with a higher risk‐adjusted MACE rate at long‐term follow‐up.
- 26 May 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 108 (2) , 426-436
PCI for Ostial Stenosis of Left Circumflex or Left Anterior Descending Artery
Background: To date, the clinical outcome of ostial stent implantation (OSI) in patients with ostial left circumflex artery (LCX) or left anterior descending artery (LAD) lesions has not been well established. This study sought to assess the cardiovascular outcomes of the ostial stent implantation (OSI) for the ostial LAD or LCX lesions under long‐term follow‐up. Methods: This large‐scale, multicenter ( n = 13) observational, retrospective study included 839 patients (men: 619 [73.8%], mean age: 61.36 ± 11.93 years) who underwent PCI with OSI for ostial LAD or LCX lesions between 2014 and 2025. The primary outcome was major adverse cardiac events (MACE), including cardiac death, target lesion revascularisation, and target vessel myocardial infarction. Results: The study cohort was divided into two groups: ostial LAD ( n = 590) and ostial LCX ( n = 249) revascularized with OSI. SYNTAX scores and the utilization of intravascular imaging rates were similar in both groups. Total stent length (22.79 ± 7.37 vs. 24.60 ± 7.57 mm, p = 0.001) was notably lower in the LCX group; however, the rate of bailout 2‐stent technique (6.4 vs. 2.7%, p = 0.010) was significantly higher in the LCX group than in the LAD group. The risk‐adjusted long‐term MACE (HR: 1.591, p = 0.010) significantly differed in individuals with left‐sided ostial lesions to revascularize with OSI. Additionally, diabetes mellitus, chronic kidney disease, intravascular imaging, reduced left ventricle ejection fraction, high SYNTAX score, statin usage, and total stent length were found to be independent predictors of MACE. Conclusions: This multicenter study demonstrates that the location of ostial stenosis in LCX was associated with a higher risk‐adjusted MACE rate at long‐term follow‐up.
- Open Access
- 19 March 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Endothelial Activation and Stress Index (EASIX) as a novel index associated with no-reflow phenomenon in STEMI: a bi-center retrospective study
No-reflow phenomenon (NRP) after primary PCI in STEMI is strongly linked to early mortality and adverse events. Conventional indices such as the systemic immune-inflammation index (SII), the CRP to albumin ratio (CAR), and the SYNTAX 1 score (SXscore) appear to provide only moderate discrimination for NRP. The endothelial activation and stress index (EASIX), calculated as LDH × creatinine / platelet count, reflects endothelial dysfunction and microvascular stress and may add to risk stratification. This two-center retrospective cohort study included 983 consecutive STEMI patients undergoing primary PCI. NRP was defined as the failure to achieve distal TIMI 3 flow despite a fully patent epicardial artery, or the need for pharmacological therapy to reverse NRP. We evaluated the relationships of EASIX, SII, CAR and SXscore with NRP; key exclusion criteria were non-ticagrelor P2Y12 loading, advanced renal/hepatic failure, active infection/inflammatory–hematologic disease or malignancy, shock/arrest (Killip ≥ 2), door-to-balloon time > 60 min, prior CABG/PCI, and pre-PCI fibrinolytic therapy. NRP occurred in 267 patients (27.2%). EASIX, SII, CAR and SXscore were significantly higher in the NRP (+) group (all p < 0.001). In multivariable models, EASIX (OR 18.97, 95% CI 11.83–30.43; p < 0.001), CAR (OR 2.45, 95% CI 1.90–3.16; p < 0.001), SII (OR 1.000, 95% CI 1.000–1.000; p = 0.003), and SXscore (OR 1.04, 95% CI 1.03–1.06; p < 0.001) were independently associated with NRP. In ROC analysis, EASIX demonstrated the highest discriminative ability for predicting NRP (AUC = 0.835). The optimal cut-off value of 1.248 provided 62.2% sensitivity and 93.6% specificity. In comparison, CAR, SII, and SXscore showed lower discrimination (AUC = 0.687, 0.562, and 0.583, respectively). EASIX demonstrated a stronger association with NRP than CAR, SII, and the SXscore. Easily derived from routine laboratory tests, EASIX may represent a practical and readily applicable index for early NRP risk stratification in STEMI.
- 19 March 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessEndothelial Activation and Stress Index (EASIX) as a novel index associated with no-reflow phenomenon in STEMI: a bi-center retrospective study
No-reflow phenomenon (NRP) after primary PCI in STEMI is strongly linked to early mortality and adverse events. Conventional indices such as the systemic immune-inflammation index (SII), the CRP to albumin ratio (CAR), and the SYNTAX 1 score (SXscore) appear to provide only moderate discrimination for NRP. The endothelial activation and stress index (EASIX), calculated as LDH × creatinine / platelet count, reflects endothelial dysfunction and microvascular stress and may add to risk stratification. This two-center retrospective cohort study included 983 consecutive STEMI patients undergoing primary PCI. NRP was defined as the failure to achieve distal TIMI 3 flow despite a fully patent epicardial artery, or the need for pharmacological therapy to reverse NRP. We evaluated the relationships of EASIX, SII, CAR and SXscore with NRP; key exclusion criteria were non-ticagrelor P2Y12 loading, advanced renal/hepatic failure, active infection/inflammatory–hematologic disease or malignancy, shock/arrest (Killip ≥ 2), door-to-balloon time > 60 min, prior CABG/PCI, and pre-PCI fibrinolytic therapy. NRP occurred in 267 patients (27.2%). EASIX, SII, CAR and SXscore were significantly higher in the NRP (+) group (all p < 0.001). In multivariable models, EASIX (OR 18.97, 95% CI 11.83–30.43; p < 0.001), CAR (OR 2.45, 95% CI 1.90–3.16; p < 0.001), SII (OR 1.000, 95% CI 1.000–1.000; p = 0.003), and SXscore (OR 1.04, 95% CI 1.03–1.06; p < 0.001) were independently associated with NRP. In ROC analysis, EASIX demonstrated the highest discriminative ability for predicting NRP (AUC = 0.835). The optimal cut-off value of 1.248 provided 62.2% sensitivity and 93.6% specificity. In comparison, CAR, SII, and SXscore showed lower discrimination (AUC = 0.687, 0.562, and 0.583, respectively). EASIX demonstrated a stronger association with NRP than CAR, SII, and the SXscore. Easily derived from routine laboratory tests, EASIX may represent a practical and readily applicable index for early NRP risk stratification in STEMI.
- 3 March 2025
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 19 (6) , 187-195
The relationship between serum Lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young individuals. Lumican, is an indicator of fibrosis. We aimed to evaluate the relation between serum Lumican levels and presence and extent of myocardial fibrosis in HCM. The patients diagnosed with HCM between June 2022 and March 2023 were enrolled consecutively in this prospective study. Age and gender-matched healthy individuals formed control group. Two groups were generated according to extent of late gadolinium enhancement (LGE) in HCM patients. A total of 114 patients were enrolled. Serum Lumican, NT-proBNP levels and maximum wall thickness were revealed as independent risk factors associated with LGE. A cut-off value of 9.06 for Lumican was associated with 67.8% sensitivity and 65.5% specificity in prediction of LGE. Myocardial fibrosis is one of the important mechanisms in HCM pathophysiology. LGE on cardiac magnetic resonance imaging allows comprehensive evaluation of myocardial fibrosis, the support of diagnosis with a biomarker would be beneficial in clinical practice. Our study revealed that serum Lumican level is an independent predictor of severe LGE in HCM patients. Further studies with larger patient numbers may clarify the importance of Lumican in HCM pathophysiology.
- 3 March 2025
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 19 (6) , 187-195
The relationship between serum Lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young individuals. Lumican, is an indicator of fibrosis. We aimed to evaluate the relation between serum Lumican levels and presence and extent of myocardial fibrosis in HCM. The patients diagnosed with HCM between June 2022 and March 2023 were enrolled consecutively in this prospective study. Age and gender-matched healthy individuals formed control group. Two groups were generated according to extent of late gadolinium enhancement (LGE) in HCM patients. A total of 114 patients were enrolled. Serum Lumican, NT-proBNP levels and maximum wall thickness were revealed as independent risk factors associated with LGE. A cut-off value of 9.06 for Lumican was associated with 67.8% sensitivity and 65.5% specificity in prediction of LGE. Myocardial fibrosis is one of the important mechanisms in HCM pathophysiology. LGE on cardiac magnetic resonance imaging allows comprehensive evaluation of myocardial fibrosis, the support of diagnosis with a biomarker would be beneficial in clinical practice. Our study revealed that serum Lumican level is an independent predictor of severe LGE in HCM patients. Further studies with larger patient numbers may clarify the importance of Lumican in HCM pathophysiology.
- Open Access
- 14 August 2023
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 4 (3) , 308-313
The association between hemogram parameters and the development of contrast-induced nephropathy in patients presenting with non-ST-elevation myocardial infarction
Objectives: Hemogram parameters such as mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLr), red cell distribution width and platelet distribution width are widely used inflammatory indicators to assess prognosis in various cardiovascular diseases. In this study, we aimed to investigate the role of hemogram parameters to predict the development of contrast-induced nephropathy (CIN) in patients presenting with non-ST segment elevation myocardial infarction (non-STEMI) and treated with percutaneous coronary intervention (PCI). Methods: All pateints who underwent PCI with a diagnosis of non-STEMI between 2017 and 2020 in our center were included retrospectively in this study. Results: A total of 387 patients were included in this retrospective study. Advanced age (p=0.001, β:0.005, OR [95 % CI]: 0.002–0.007), diabetes mellitus (p=0.013, β:0.205, OR [95 % CI]: 0.150–0.260), congestive heart failure (p=0.009, β:0.095, OR [95 % CI]: 0.024–0.166), volume of contrast medium (p=0.008, β:0.241, OR [95 % CI]: 0.184–0.392), MPV (p=0.02, β:0.047, OR [95 % CI]: 0.028–0.065) and NLr (p=0.001, β:0.052, OR [95 % CI]: 0.040–0.063) were found as independent risk factors associated with CIN development according to multivariate logistic regression analysis. A cut off value of 5.5 for NLr was associated with 79.6 % sensitivity and 79.5 % specificity and 9.05 for MPV was associated with 64.1 % sensitivity and 58.7 % specificity in prediction of CIN development. Conclusions: Hematological parameters, assessed by routine blood count analysis may serve as a promising and useful marker for CIN especially when used in combination with traditional risk factors. MPV and NLr were demonstrated as predictors of CIN development in non-STEMI patients who were treated with PCI in our study.
- 14 August 2023
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 4 (3) , 308-313
Open AccessThe association between hemogram parameters and the development of contrast-induced nephropathy in patients presenting with non-ST-elevation myocardial infarction
Objectives: Hemogram parameters such as mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLr), red cell distribution width and platelet distribution width are widely used inflammatory indicators to assess prognosis in various cardiovascular diseases. In this study, we aimed to investigate the role of hemogram parameters to predict the development of contrast-induced nephropathy (CIN) in patients presenting with non-ST segment elevation myocardial infarction (non-STEMI) and treated with percutaneous coronary intervention (PCI). Methods: All pateints who underwent PCI with a diagnosis of non-STEMI between 2017 and 2020 in our center were included retrospectively in this study. Results: A total of 387 patients were included in this retrospective study. Advanced age (p=0.001, β:0.005, OR [95 % CI]: 0.002–0.007), diabetes mellitus (p=0.013, β:0.205, OR [95 % CI]: 0.150–0.260), congestive heart failure (p=0.009, β:0.095, OR [95 % CI]: 0.024–0.166), volume of contrast medium (p=0.008, β:0.241, OR [95 % CI]: 0.184–0.392), MPV (p=0.02, β:0.047, OR [95 % CI]: 0.028–0.065) and NLr (p=0.001, β:0.052, OR [95 % CI]: 0.040–0.063) were found as independent risk factors associated with CIN development according to multivariate logistic regression analysis. A cut off value of 5.5 for NLr was associated with 79.6 % sensitivity and 79.5 % specificity and 9.05 for MPV was associated with 64.1 % sensitivity and 58.7 % specificity in prediction of CIN development. Conclusions: Hematological parameters, assessed by routine blood count analysis may serve as a promising and useful marker for CIN especially when used in combination with traditional risk factors. MPV and NLr were demonstrated as predictors of CIN development in non-STEMI patients who were treated with PCI in our study.
- Open Access
- 22 March 2023
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 13 (2) , 182-186
The Utility of Glasgow Prognostic Score as an Indicator of Mortality After Transcatheter Aortic Valve Implantation
Aim The Glasgow Prognostic Score (GPS) is a scoring system obtained by using inflammatory (C-reactive protein) and nutritional (albumin) parameters together, and it has been shown to have prognostic value in various cardiac pathologies in previous studies. In this study, we aimed to investigate the usability of the Glasgow Prognostic Score (GPS) in predicting 1-year mortality in patients who underwent transcatheter aortic valve implantation (TAVI). Method Patients who underwent TAVI with the diagnosis of severe, symptomatic aortic stenosis in our hospital between 2013 and 2017 were included in this single center study retrospectively. Demographic, clinical and laboratory data were obtained by reviewing patient files. GPS value was calculated by using C-reactive protein and albumin values which was obtained on admission to. Two groups were formed as survivors and non-survivors according to 1-year mortality data. Results A total of 170 patients were included in this retrospective study and 59 patients constituted the non-survivors group. History of chronic obstructive pulmonary disease and cerebrovascular disease were higher in non-survivors’ group. High STS-TAVR, Euro SCORE II and GPS levels were also higher in non-survivors group. High GPS value calculated with pre-procedural data was determined as a predictor of 1-year mortality. Conclusion The Glasgow Prognostic Score allows the evaluation of inflammation and nutritional status together, is a practical method that can be obtained from routine laboratory parameters. It can be used as a predictor of mortality in patients undergoing TAVI. It can guide clinicians in taking preventive measures to reduce mortality before the procedure.
- 22 March 2023
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 13 (2) , 182-186
Open AccessThe Utility of Glasgow Prognostic Score as an Indicator of Mortality After Transcatheter Aortic Valve Implantation
Aim The Glasgow Prognostic Score (GPS) is a scoring system obtained by using inflammatory (C-reactive protein) and nutritional (albumin) parameters together, and it has been shown to have prognostic value in various cardiac pathologies in previous studies. In this study, we aimed to investigate the usability of the Glasgow Prognostic Score (GPS) in predicting 1-year mortality in patients who underwent transcatheter aortic valve implantation (TAVI). Method Patients who underwent TAVI with the diagnosis of severe, symptomatic aortic stenosis in our hospital between 2013 and 2017 were included in this single center study retrospectively. Demographic, clinical and laboratory data were obtained by reviewing patient files. GPS value was calculated by using C-reactive protein and albumin values which was obtained on admission to. Two groups were formed as survivors and non-survivors according to 1-year mortality data. Results A total of 170 patients were included in this retrospective study and 59 patients constituted the non-survivors group. History of chronic obstructive pulmonary disease and cerebrovascular disease were higher in non-survivors’ group. High STS-TAVR, Euro SCORE II and GPS levels were also higher in non-survivors group. High GPS value calculated with pre-procedural data was determined as a predictor of 1-year mortality. Conclusion The Glasgow Prognostic Score allows the evaluation of inflammation and nutritional status together, is a practical method that can be obtained from routine laboratory parameters. It can be used as a predictor of mortality in patients undergoing TAVI. It can guide clinicians in taking preventive measures to reduce mortality before the procedure.
- 14 March 2023
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 8 (1) , 47-52
The Usage of Prognostic Nutritional Index to Predict Postoperative Atrial Fibrillation Development
- 14 March 2023
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 8 (1) , 47-52
The Usage of Prognostic Nutritional Index to Predict Postoperative Atrial Fibrillation Development
- 1 December 2022
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 7 (4) , 357-353
Outcomes of Hospitalized Patients with Infective Endocarditis: A Tertiary Center Experience
- 1 December 2022
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 7 (4) , 357-353
Outcomes of Hospitalized Patients with Infective Endocarditis: A Tertiary Center Experience
- 14 April 2022
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 7 (1) , 32-37
The Role of MPV-to-Lymphocyte Ratio and MPVto- Platelet Ratio in Predicting Mortality in Patients with Acute Myocardial Infarction
- 14 April 2022
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 7 (1) , 32-37
The Role of MPV-to-Lymphocyte Ratio and MPVto- Platelet Ratio in Predicting Mortality in Patients with Acute Myocardial Infarction